Alfred Guirguis

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Ignace Vergote, José Alejandro Pérez Fidalgo, Erika Hamilton et al. · Journal of Clinical Oncology · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer

D.R. Dolly, Andreea Mihai, B.J. Rimel et al. · Frontiers in Oncology · 2016 · 56 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer

Bhavana Pothuri, Alfred Guirguis, Hans Gerdes et al. · Gynecologic Oncology · 2004 · 53 citations

Medicine, Oncology, Surgery +16

Differential Analysis of Ovarian and Endometrial Cancers Identifies a Methylator Phenotype

Diana L. Kolbe, Julie A. DeLoia, Patricia Porter‐Gill et al. · PLoS ONE · 2012 · 46 citations · Full text

Medicine, Genetics, Oncology +16